Universal Mask Usage for Reduction of Respiratory Viral Infections After Stem Cell Transplant: A Prospective Trial
Conclusions. Requiring all individuals with direct patient contact to wear a surgical mask is associated with a reduction in RVIs, particularly PIV3, during the most vulnerable period following HSCT.
Source: Clinical Infectious Diseases - Category: Infectious Diseases Authors: Sung, A. D., Sung, J. A. M., Thomas, S., Hyslop, T., Gasparetto, C., Long, G., Rizzieri, D., Sullivan, K. M., Corbet, K., Broadwater, G., Chao, N. J., Horwitz, M. E. Tags: ARTICLES AND COMMENTARIES Source Type: research
More News: Cancer & Oncology | Hematology | Infectious Diseases | Respiratory Medicine | Stem Cell Therapy | Stem Cells | Study | Transplants